Jobdetails

Titel

Molecular Pathology Research Laboratory Head - Cancer Research/Biomarkers and Translational Research (m/f)

Dienstort Vienna Unternehmen Boehringer Ingelheim RCV GmbH & Co KG
Arbeitgeber entdecken
Beschäftigungsart Vollzeit Position ohne Personalverantwortung Gehaltsangabe 47.207,30 € /brutto Jetzt bewerben

Grow with us!

Molecular Pathology Research Laboratory Head - Cancer Research/Biomarkers and Translational Research (m/f)

Wien

Boehringer Ingelheim Top Employer Austria
Job-ID: 178166
Job level: n/a
Functional area: Research & Development
Schedule: Full-time

Boehringer Ingelheim RCV Vienna is home to Boehringer Ingelheim's dedicated drug discovery center for innovative cancer medicines. A team of more than 200 scientists and technicians, combining their expertise in cancer biology and genomics, pharmacology, medicinal chemistry, structural research, high-throughput screening and discovery ADME, drive our efforts to identify novel medication for the treatment of cancer. In the Department of Pharmacology we are currently looking for a highly motivated and result oriented scientist (m/f) to serve as a Molecular Pathology Research Laboratory Head in the Biomarker and Translational Research Group in Oncology. The Biomarker and Translational Research Group contributes to the identification and validation of patient selection biomarkers as well as pharmacodynamic biomarkers in alignment with the respective project teams in research, preclinical and clinical development. Moreover the group is heavily involved in the characterization of the mode of action of novel cancer cell directed and immune-oncology drugs.

Duties & Responsibilities

  • Lead an experimental pathology laboratory that performs histopathological and molecular characterization of cancer disease relevant models and human samples to understand the target-disease link
  • Design and pre-clinically validate fit-for-purpose IHC and other tissue-based assays
  • Support the development of capabilities of the histopathology group, including multiplex assays and quantitative image analysis using digital pathology platforms
  • Profile drug candidates to identify predictive and pharmacodynamic biomarkers to support development of cancer cell directed and immunotherapies
  • Provide scientific expertise for state-of-the-art oncology pathology biomarkers for discovery and early clinical development
  • Coordinate effectively with other research teams and disciplines across the global Discovery Research Organization
  • Establish and manage external collaborations with academic partners and CROs, including evaluation of new technologies
  • Assumes responsibility for direct reports as needed including recruiting, managing, mentoring and developing scientific staff

For this position we offer an interesting salary considering your expertise and personal competencies as well as your professional experience. We are obliged by law to state the minimum salary according to the collective agreement, which amounts to € 47,207.30 gross per year (full-time) for this position. An overpayment is possible. Moreover, we offer our employees a variety of attractive social benefits which will be introduced in the personal interview.

Requirements

  • PhD or MD, with postdoctoral training and/or research/clinical experience in the fields of tumor histopathology and molecular biology
  • In depth knowledge of immunohistochemistry procedures including: tissue dissection, routine histology, immunohistochemistry (IHC), in-situ hybridization (ISH), and image capture of fresh, frozen and paraffin-embedded tissues and digital pathology approaches
  • Demonstrated ability to work in multi-disciplinary teams
  • Ability to work independently, plan, organize, troubleshoot, present work and to show team leadership
  • Good organization and communication skills

Our Culture

Innovative medicines for people and animals have for more than 130 years been what the research-driven pharmaceutical company Boehringer Ingelheim stands for. Boehringer Ingelheim is one of the pharmaceutical industry's top 20 companies and to this day remains family-owned. Day by day, some 50,000 employees create value through innovation for the three business areas human pharmaceuticals, animal health and biopharmaceutical contract manufacturing. In 2016, Boehringer Ingelheim achieved net sales of around 15.9 billion euros. With more than three billion euros, R&D expenditure corresponds to 19.6 per cent of net sales.

Contact

Your application will be reviewed by our recruiting team as well as the respective department. Therefore, we do not state a specific contact person and kindly ask you to use a general salutation in your application.
Jobempfehlung senden
Folgenden Job empfehlen:
Molecular Pathology Research Laboratory Head - Cancer Research/Biomarkers and Translational Research (m/f)

abbrechen
Möchten Sie sich anmelden?

Um Ihre Merkliste dauerhaft zu speichern, melden Sie sich bitte mit Ihrem derStandard.at Benutzerkonto an.

Falls Sie noch kein derStandard.at Benutzkonto besitzen können Sie sich kostenlos registrieren


Ohne Anmeldung fortfahren Anmelden